CD4 and tuberculosis: Later presentation to a health facility, diagnosis processes, opportunistic infections or immune reconstitution syndrome may contribute to such high proportion of TB and/or HIV mortality.7,8 Commencing antiretroviral therapy (ART) and cotrimoxazole preventive therapy (CPT) in all HIV-positive TB patients regardless of WHO clinical stage or CD4 cell count are some strategies to reduce TB mortality.